Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (111-120 of 208) with videos related to

Pageof 21
Sort By:
Epigenomics|January 15, 2024
Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancerJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2023
Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer OutcomesJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Journal of Neurosurgery|September 26, 2019
Phase I trial of caudate deep brain stimulation for treatment-resistant tinnitusSteven W Cheung, Caroline A Racine, Jennifer Henderson-Sabes, et al.
Neurosurgery|May 26, 2017
Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with SeizurePatrick M Flanigan, Arman Jahangiri, Ruby Kuang, et al.
Clinical Epigenetics|February 22, 2022
A core of differentially methylated CpG loci in gMDSCs isolated from neonatal and adult sourcesIsabella Berglund-Brown, Emily Nissen, Devin C Koestler, et al.
Journal of Neuropathology and Experimental Neurology|April 9, 2015
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomasGerald F Reis, Melike Pekmezci, Helen M Hansen, et al.
Journal of Neuro-Oncology|August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastomaJennie W Taylor, Mili Parikh, Joanna J Phillips, et al.
Neurosurgical Focus|June 2, 2018
Disparities in health care determine prognosis in newly diagnosed glioblastomaAnkush Chandra, Jonathan W Rick, Cecilia Dalle Ore, et al.
Oncotarget|October 15, 2016
GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activityOlle R Lindberg, Andrew McKinney, Jane R Engler, et al.
Scientific Reports|June 10, 2021
Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histologyMelike Pekmezci, Ramin A Morshed, Pranathi Chunduru, et al.
Pageof 21

Showing results (111-120 of 208) with videos related to

Sort By:
Pageof 21
Epigenomics|January 15, 2024
Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancerJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2023
Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer OutcomesJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Journal of Neurosurgery|September 26, 2019
Phase I trial of caudate deep brain stimulation for treatment-resistant tinnitusSteven W Cheung, Caroline A Racine, Jennifer Henderson-Sabes, et al.
Neurosurgery|May 26, 2017
Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with SeizurePatrick M Flanigan, Arman Jahangiri, Ruby Kuang, et al.
Clinical Epigenetics|February 22, 2022
A core of differentially methylated CpG loci in gMDSCs isolated from neonatal and adult sourcesIsabella Berglund-Brown, Emily Nissen, Devin C Koestler, et al.
Journal of Neuropathology and Experimental Neurology|April 9, 2015
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomasGerald F Reis, Melike Pekmezci, Helen M Hansen, et al.
Journal of Neuro-Oncology|August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastomaJennie W Taylor, Mili Parikh, Joanna J Phillips, et al.
Neurosurgical Focus|June 2, 2018
Disparities in health care determine prognosis in newly diagnosed glioblastomaAnkush Chandra, Jonathan W Rick, Cecilia Dalle Ore, et al.
Oncotarget|October 15, 2016
GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activityOlle R Lindberg, Andrew McKinney, Jane R Engler, et al.
Scientific Reports|June 10, 2021
Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histologyMelike Pekmezci, Ramin A Morshed, Pranathi Chunduru, et al.
Pageof 21